Network Subgraph-based Method: Alignment-free Technique for Molecular Network Analysis

Page: [777 - 792] Pages: 16

  • * (Excluding Mailing and Handling)

Abstract

Background: Comparing directed networks using the alignment-free technique offers the advantage of detecting topologically similar regions that are independent of the network size or node identity.

Objective: We propose a novel method to compare directed networks by decomposing the network into small modules, the so-called network subgraph approach, which is distinct from the network motif approach because it does not depend on null model assumptions.

Method: We developed an alignment-free algorithm called the Subgraph Identification Algorithm (SIA, which could generate all subgraphs that have five connected nodes (5-node subgraph). There were 9,364 such modules. Then, we applied the SIA method to examine 17 cancer networks and measured the similarity between the two networks by gauging the similarity level using Jensen- Shannon entropy (HJS).

Results: We identified and examined the biological meaning of 5-node regulatory modules and pairs of cancer networks with the smallest HJS values. The two pairs of networks that show similar patterns are (i) endometrial cancer and hepatocellular carcinoma and (ii) breast cancer and pathways in cancer. Some studies have provided experimental data supporting the 5-node regulatory modules.

Conclusion: Our method is an alignment-free approach that measures the topological similarity of 5-node regulatory modules and aligns two directed networks based on their topology. These modules capture complex interactions among multiple genes that cannot be detected using existing methods that only consider single-gene relations. We analyzed the biological relevance of the regulatory modules and used the subgraph method to identify the modules that shared the same topology across 2 cancer networks out of 17 cancer networks. We validated our findings using evidence from the literature.

[1]
Kelley BP. PathBLAST: A tool for alignment of protein interaction networks. Nucleic Acids Res 2004; 32: W83-8.
[http://dx.doi.org/10.1093/nar/gkh411]
[2]
Flannick J, Novak A, Do CB, Srinivasan BS, Batzoglou S. Automatic parameter learning for multiple local network alignment. J Comput Biol 2009; 16(8): 1001-22.
[http://dx.doi.org/10.1089/cmb.2009.0099] [PMID: 19645599]
[3]
Yaveroğlu ÖN, Milenković T, Pržulj N. Proper evaluation of alignment-free network comparison methods. Bioinformatics 2015; 31(16): 2697-704.
[http://dx.doi.org/10.1093/bioinformatics/btv170] [PMID: 25810431]
[4]
Tantardini M, Ieva F, Tajoli L, Piccardi C. Comparing methods for comparing networks. Sci Rep 2019; 9(1): 17557.
[http://dx.doi.org/10.1038/s41598-019-53708-y] [PMID: 31772246]
[5]
Pržulj N. Biological network comparison using graphlet degree distribution. Bioinformatics 2007; 23(2): e177-83.
[http://dx.doi.org/10.1093/bioinformatics/btl301] [PMID: 17237089]
[6]
Kuchaiev O, Pržulj N. Integrative network alignment reveals large regions of global network similarity in yeast and human. Bioinformatics 2011; 27(10): 1390-6.
[http://dx.doi.org/10.1093/bioinformatics/btr127] [PMID: 21414992]
[7]
Bagrow JP, Bollt EM. An information-theoretic, all-scales approach to comparing networks. Appl Netw Sci 2019; 4(1): 45.
[http://dx.doi.org/10.1007/s41109-019-0156-x]
[8]
Sarajlić A, Malod-Dognin N, Yaveroğlu ÖN, Pržulj N. Graphlet-based characterization of directed networks. Sci Rep 2016; 6(1): 35098.
[http://dx.doi.org/10.1038/srep35098] [PMID: 27734973]
[9]
Zenil H, Kiani NA, Tegnér J. Quantifying loss of information in network-based dimensionality reduction techniques. J Complex Netw 2016; 4(3): 342-62.
[http://dx.doi.org/10.1093/comnet/cnv025]
[10]
Zenil H, Kiani NA, Tegnér J. Algorithmic complexity of motifs clusters superfamilies of networks. IEEE International Conference on Bioinformatics and Biomedicine. Shanghai, China. 2013; 18-21. Dec;
[http://dx.doi.org/10.1109/BIBM.2013.6732768]
[11]
Trpevski I, Dimitrova T, Boshkovski T, Stikov N, Kocarev L. Graphlet characteristics in directed networks. Sci Rep 2016; 6(1): 37057.
[http://dx.doi.org/10.1038/srep37057] [PMID: 27830769]
[12]
Martin AJM, Dominguez C, Contreras-Riquelme S, Holmes DS, Perez-Acle T. Graphlet based metrics for the comparison of gene regulatory networks. PLoS One 2016; 11(10): e0163497.
[http://dx.doi.org/10.1371/journal.pone.0163497] [PMID: 27695050]
[13]
Wernicke S, Rasche F. FANMOD: A tool for fast network motif detection. Bioinformatics 2006; 22(9): 1152-3.
[http://dx.doi.org/10.1093/bioinformatics/btl038] [PMID: 16455747]
[14]
Martin AJ, Contreras-Riquelme S, Dominguez C, Perez-Acle T. LoTo: A graphlet based method for the comparison of local topology between gene regulatory networks. PeerJ 2017; 5: e3052.
[http://dx.doi.org/10.7717/peerj.3052] [PMID: 28265516]
[15]
Meira LAA, Máximo VR, Fazenda AL, da Conceição AF. acc-Motif: Accelerated network motif detection. IEEE/ACM Trans Comput Biol Bioinformatics 2014; 11(5): 853-62.
[http://dx.doi.org/10.1109/TCBB.2014.2321150] [PMID: 26356858]
[16]
Stivala A, Lomi A. Testing biological network motif significance with exponential random graph models. Appl Netw Sci 2021; 6(1): 91.
[http://dx.doi.org/10.1007/s41109-021-00434-y] [PMID: 34841042]
[17]
Huang CH, Zaenudin E, Tsai JJP, Kurubanjerdjit N, Dessie EY, Ng KL. Dissecting molecular network structures using a network subgraph approach. PeerJ 2020; 8: e9556-6.
[http://dx.doi.org/10.7717/peerj.9556] [PMID: 33005483]
[18]
Huang CH, Zaenudin E, Tsai JJP, Kurubanjerdjit N, Ng KL. Network subgraph-based approach for analyzing and comparing molecular networks. PeerJ 2022; 10: e13137.
[http://dx.doi.org/10.7717/peerj.13137] [PMID: 35529499]
[19]
Heymans M, Singh AK. Deriving phylogenetic trees from the similarity analysis of metabolic pathways. Bioinformatics 2003; 19: i138-46.
[http://dx.doi.org/10.1093/bioinformatics/btg1018] [PMID: 12855450]
[20]
Zhu D, Qin ZS. Structural comparison of metabolic networks in selected single cell organisms. BMC Bioinformatics 2005; 6(1): 8.
[http://dx.doi.org/10.1186/1471-2105-6-8] [PMID: 15649332]
[21]
Aparicio D, Ribeiro P, Silva F. Extending the applicability of graphlets to directed networks. IEEE/ACM Trans Comput Biol Bioinform 2017; 14(6): 1302-5.
[http://dx.doi.org/10.1109/TCBB.2016.2586046]
[22]
Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U. Network motifs: Simple building blocks of complex networks. Science 2002; 298(5594): 824-7.
[http://dx.doi.org/10.1126/science.298.5594.824] [PMID: 12399590]
[23]
Zhang Q, Bhattacharya S, Conolly RB, Clewell HJ III, Kaminski NE, Andersen ME. Molecular signaling network motifs provide a mechanistic basis for cellular threshold responses. Environ Health Perspect 2014; 122(12): 1261-70.
[http://dx.doi.org/10.1289/ehp.1408244] [PMID: 25117432]
[24]
Widder S, Schicho J, Schuster P. Dynamic patterns of gene regulation I: Simple two-gene systems. J Theor Biol 2007; 246(3): 395-419.
[http://dx.doi.org/10.1016/j.jtbi.2007.01.004] [PMID: 17337276]
[25]
Ahnert SE, Fink TMA. Form and function in gene regulatory networks: The structure of network motifs determines fundamental properties of their dynamical state space. J R Soc Interface 2016; 13(120): 20160179.
[http://dx.doi.org/10.1098/rsif.2016.0179] [PMID: 27440255]
[26]
Burack WR, Shaw AS. Signal transduction: Hanging on a scaffold. Curr Opin Cell Biol 2000; 12(2): 211-6.
[http://dx.doi.org/10.1016/S0955-0674(99)00078-2] [PMID: 10712921]
[27]
Efendi Z, Huang CH, Ng KL. Identifying network subgraph-associated essential genes in molecular networks using a network subgraph approach. Int J Math Comput Sci 2021; 15(5): 2021.
[28]
Qi H, Pei D. The magic of four: Induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4. Cell Res 2007; 17(7): 578-80.
[http://dx.doi.org/10.1038/cr.2007.59] [PMID: 17632550]
[29]
van Schaijik B, Davis PF, Wickremesekera AC, Tan ST, Itinteang T. Subcellular localisation of the stem cell markers OCT4, SOX2, NANOG, KLF4 and c-MYC in cancer: A review. J Clin Pathol 2018; 71(1): 88-91.
[http://dx.doi.org/10.1136/jclinpath-2017-204815] [PMID: 29180509]
[30]
Villodre ES, Felipe KB, Oyama MZ, et al. Silencing of the transcription factors Oct4, Sox2, Klf4, c-Myc or Nanog has different effect on teratoma growth. Biochem Biophys Res Commun 2019; 517(2): 324-9.
[http://dx.doi.org/10.1016/j.bbrc.2019.07.064] [PMID: 31353083]
[31]
Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010; 38(Database issue): D355-60.
[http://dx.doi.org/10.1093/nar/gkp896] [PMID: 19880382]
[32]
Efendi Zaenudin EBW. A parallel algorithm to generate connected network motifs. IAENG Int J Comput Sci 2019; 46(4): 518-23.
[33]
Kugler KG, Mueller LAJ, Graber A, Dehmer M. Integrative network biology: Graph prototyping for co-expression cancer networks. PLoS One 2011; 6(7): e22843.
[http://dx.doi.org/10.1371/journal.pone.0022843] [PMID: 21829532]
[34]
Lin J. Divergence measures based on the Shannon entropy. IEEE Trans Inf Theory 1991; 37(1): 145-51.
[http://dx.doi.org/10.1109/18.61115]
[35]
Stirewalt DL, Radich JP. The role of FLT3 in haematopoietic malignancies. Nat Rev Cancer 2003; 3(9): 650-65.
[http://dx.doi.org/10.1038/nrc1169] [PMID: 12951584]
[36]
Takahashi S. Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: Biology and therapeutic implications. J Hematol Oncol 2011; 4(1): 13.
[http://dx.doi.org/10.1186/1756-8722-4-13] [PMID: 21453545]
[37]
Mizuki M, Schwäble J, Steur C, et al. Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations. Blood 2003; 101(8): 3164-73.
[http://dx.doi.org/10.1182/blood-2002-06-1677] [PMID: 12468433]
[38]
Chen YJ, Lee LY, Chao YK, et al. DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway. PLoS One 2013; 8(5): e64088.
[http://dx.doi.org/10.1371/journal.pone.0064088] [PMID: 23737966]
[39]
Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X. Targeting PI3K in cancer: Mechanisms and advances in clinical trials. Mol Cancer 2019; 18(1): 26.
[http://dx.doi.org/10.1186/s12943-019-0954-x] [PMID: 30782187]
[40]
Huang R, Dai Q, Yang R, et al. A Review: PI3K/AKT/mTOR signaling pathway and its regulated eukaryotic translation initiation factors may be a potential therapeutic target in esophageal squamous cell carcinoma. Front Oncol 2022; 12: 817916.
[http://dx.doi.org/10.3389/fonc.2022.817916] [PMID: 35574327]
[41]
Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst 2015; 1(6): 417-25.
[http://dx.doi.org/10.1016/j.cels.2015.12.004] [PMID: 26771021]
[42]
Haupt S, Berger M, Goldberg Z, Haupt Y. Apoptosis - the p53 network. J Cell Sci 2003; 116(20): 4077-85.
[http://dx.doi.org/10.1242/jcs.00739] [PMID: 12972501]
[43]
Wen J, Chen X, Liu X, et al. Small nucleolar RNA and C/D Box 15B regulate the TRIM25/P53 Complex to promote the development of endometrial cancer. J Oncol 2022; 2022: 1-13.
[http://dx.doi.org/10.1155/2022/7762708] [PMID: 36199797]
[44]
Roh J, Kim J, Park N, et al. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer1. Gynecol Oncol 2004; 93(2): 499-505.
[http://dx.doi.org/10.1016/j.ygyno.2004.02.005] [PMID: 15099969]
[45]
Costa BP, Nassr MT, Diz FM, et al. Methoxyeugenol regulates the p53/p21 pathway and suppresses human endometrial cancer cell proliferation. J Ethnopharmacol 2021; 267: 113645.
[http://dx.doi.org/10.1016/j.jep.2020.113645] [PMID: 33271245]
[46]
Ou X, Lu Y, Liao L, et al. Nitidine chloride induces apoptosis in human hepatocellular carcinoma cells through a pathway involving p53, p21, Bax and Bcl-2. Oncol Rep 2015; 33(3): 1264-74.
[http://dx.doi.org/10.3892/or.2014.3688] [PMID: 25530218]
[47]
Shi Y-Z, Hui A-M, Takayama T, Li X, Cui X, Makuuchi M. Reduced p21WAF1/CIP1 protein expression is predominantly related to altered p53 in hepatocellular carcinomas. Br J Cancer 2000; 83(1): 50-5.
[http://dx.doi.org/10.1054/bjoc.2000.1310] [PMID: 10883667]
[48]
Lee T, Man K, Poon R, Lo CM, Ng I, Fan ST. Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma. Oncol Rep 2004; 12(1): 25-31.
[http://dx.doi.org/10.3892/or.12.1.25] [PMID: 15201954]
[49]
Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different malignancies: A new perspective. Cancer 2014; 120(22): 3446-56.
[http://dx.doi.org/10.1002/cncr.28864] [PMID: 24948110]
[50]
Hu M, Zhang Y, Li X, et al. Alterations of endometrial epithelial–mesenchymal transition and MAPK signalling components in women with PCOS are partially modulated by metformin in vitro. Mol Hum Reprod 2020; 26(5): 312-26.
[http://dx.doi.org/10.1093/molehr/gaaa023] [PMID: 32202622]
[51]
Zhang F, Ni ZJ, Ye L, et al. Asparanin A inhibits cell migration and invasion in human endometrial cancer via Ras/ERK/MAPK pathway. Food Chem Toxicol 2021; 150: 112036.
[http://dx.doi.org/10.1016/j.fct.2021.112036] [PMID: 33561516]
[52]
Jiang J, Zhou N, Ying P, Zhang T, Liang R, Jiang X. Emodin promotes apoptosis of human endometrial cancer through regulating the MAPK and PI3K/AKT pathways. Open Life Sci 2019; 13(1): 489-96.
[http://dx.doi.org/10.1515/biol-2018-0058] [PMID: 33817118]
[53]
Zhang W, Liu M, Ji Y, et al. Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway. Arch Biochem Biophys 2023; 743: 109655.
[http://dx.doi.org/10.1016/j.abb.2023.109655] [PMID: 37285895]
[54]
Moon H, Ro SW. MAPK/ERK signaling pathway in hepatocellular carcinoma. Cancers 2021; 13(12): 3026.
[http://dx.doi.org/10.3390/cancers13123026] [PMID: 34204242]
[55]
Yang Z, Zhang H, Yin M, et al. Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways. Int J Biol Sci 2022; 18(15): 5963-77.
[http://dx.doi.org/10.7150/ijbs.72982] [PMID: 36263167]
[56]
Guo P, Hu Q, Wang J, Hai L, Nie X, Zhao Q. Butorphanol inhibits angiogenesis and migration of hepatocellular carcinoma and regulates MAPK pathway. J Antibiot 2022; 75(11): 626-34.
[http://dx.doi.org/10.1038/s41429-022-00565-z] [PMID: 36131028]
[57]
Tian D, Yu Y, Zhang L, Sun J, Jiang W. 23-hydroxybetulinic acid reduces tumorigenesis, metastasis and immunosuppression in a mouse model of hepatocellular carcinoma via disruption of the MAPK signaling pathway. Anticancer Drugs 2022; 33(9): 815-25.
[http://dx.doi.org/10.1097/CAD.0000000000001325] [PMID: 36136986]
[58]
Yang S, Liu G. Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma. Oncol Lett 2017; 13(3): 1041-7.
[http://dx.doi.org/10.3892/ol.2017.5557] [PMID: 28454211]
[59]
Muthukaruppan A, Lasham A, Woad KJ, et al. Multimodal assessment of estrogen receptor mRNA profiles to quantify estrogen pathway activity in breast tumors. Clin Breast Cancer 2017; 17(2): 139-53.
[http://dx.doi.org/10.1016/j.clbc.2016.09.001] [PMID: 27756582]
[60]
Liu LC, Su CH, Wang HC, et al. Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk. Biomedicine 2014; 4(1): 3.
[http://dx.doi.org/10.7603/s40681-014-0003-4] [PMID: 25520916]
[61]
Cui Y, Zhao M, Yang Y, et al. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy. Acta Biomater 2022; 152: 380-92.
[http://dx.doi.org/10.1016/j.actbio.2022.08.024] [PMID: 36028199]
[62]
Pintor S, Lopez A, Flores D, et al. FOXO1 promotes the expression of canonical WNT target genes in examined basal‐like breast and glioblastoma multiforme cancer cells. FEBS Open Bio 2023; 13(11): 2108-23.
[http://dx.doi.org/10.1002/2211-5463.13696] [PMID: 37584250]
[63]
Akbarzadeh M, Mihanfar A, Akbarzadeh S, Yousefi B, Majidinia M. Crosstalk between miRNA and PI3K/AKT/mTOR signaling pathway in cancer. Life Sci 2021; 285: 119984.
[http://dx.doi.org/10.1016/j.lfs.2021.119984] [PMID: 34592229]
[64]
Zaidi NE, Shazali NAH, Leow TC, Osman MA, Ibrahim K, Rahman NMANA. Crosstalk between fatty acid metabolism and tumour-associated macrophages in cancer progression. Biomedicine 2022; 12(4): 9-19.
[http://dx.doi.org/10.37796/2211-8039.1381] [PMID: 36816174]
[65]
Li S, Hu H, He Z, Liang D, Sun R, Lan K. fine-tuning of the kaposi’s sarcoma-associated herpesvirus life cycle in neighboring cells through the RTA-JAG1-notch pathway. PLoS Pathog 2016; 12(10): e1005900.
[http://dx.doi.org/10.1371/journal.ppat.1005900] [PMID: 27760204]
[66]
Gu S, Liu F, Xie X, et al. β-Sitosterol blocks the LEF-1-mediated Wnt/β-catenin pathway to inhibit proliferation of human colon cancer cells. Cell Signal 2023; 104: 110585.
[http://dx.doi.org/10.1016/j.cellsig.2022.110585] [PMID: 36603684]